NOV (NOV) Competitors

$20.81 0.00 (0.00%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$20.85 +0.04 (+0.19%)

As of 05/22/2026 06:39 PM Eastern

NOV vs. BKR, PTEN, FTI, HAL, and HP

Should you buy NOV stock or one of its competitors? MarketBeat compares NOV with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NOV include Baker Hughes (BKR), Patterson-UTI Energy (PTEN), TechnipFMC (FTI), Halliburton (HAL), and Helmerich & Payne (HP). These companies are all part of the "energy" sector.

How does NOV compare to Baker Hughes?

Baker Hughes (NASDAQ:BKR) and NOV (NYSE:NOV) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

In the previous week, Baker Hughes had 11 more articles in the media than NOV. MarketBeat recorded 25 mentions for Baker Hughes and 14 mentions for NOV. Baker Hughes' average media sentiment score of 1.39 beat NOV's score of 1.03 indicating that Baker Hughes is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baker Hughes	19 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NOV	8 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baker Hughes presently has a consensus target price of $69.41, indicating a potential upside of 5.07%. NOV has a consensus target price of $19.36, indicating a potential downside of 6.98%. Given Baker Hughes' stronger consensus rating and higher possible upside, research analysts plainly believe Baker Hughes is more favorable than NOV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baker Hughes	1 Sell rating(s)	3 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.77
NOV	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.12

Baker Hughes pays an annual dividend of $0.92 per share and has a dividend yield of 1.4%. NOV pays an annual dividend of $0.36 per share and has a dividend yield of 1.7%. Baker Hughes pays out 29.4% of its earnings in the form of a dividend. NOV pays out 150.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Baker Hughes has increased its dividend for 4 consecutive years and NOV has increased its dividend for 1 consecutive years.

Baker Hughes has higher revenue and earnings than NOV. Baker Hughes is trading at a lower price-to-earnings ratio than NOV, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baker Hughes	$27.73B	2.36	$2.59B	$3.13	21.11
NOV	$8.74B	0.85	$145M	$0.24	86.71

Baker Hughes has a net margin of 11.17% compared to NOV's net margin of 1.05%. Baker Hughes' return on equity of 14.17% beat NOV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baker Hughes	11.17%	14.17%	6.24%
NOV	1.05%	3.34%	1.90%

Baker Hughes has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market. Comparatively, NOV has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market.

92.1% of Baker Hughes shares are held by institutional investors. Comparatively, 93.3% of NOV shares are held by institutional investors. 0.2% of Baker Hughes shares are held by insiders. Comparatively, 1.2% of NOV shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Baker Hughes beats NOV on 15 of the 20 factors compared between the two stocks.

How does NOV compare to Patterson-UTI Energy?

Patterson-UTI Energy (NASDAQ:PTEN) and NOV (NYSE:NOV) are both mid-cap energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

NOV has higher revenue and earnings than Patterson-UTI Energy. Patterson-UTI Energy is trading at a lower price-to-earnings ratio than NOV, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Patterson-UTI Energy	$4.83B	0.97	-$93.64M	-$0.31	N/A
NOV	$8.74B	0.85	$145M	$0.24	86.71

In the previous week, NOV had 11 more articles in the media than Patterson-UTI Energy. MarketBeat recorded 14 mentions for NOV and 3 mentions for Patterson-UTI Energy. Patterson-UTI Energy's average media sentiment score of 1.05 beat NOV's score of 1.03 indicating that Patterson-UTI Energy is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Patterson-UTI Energy	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NOV	8 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Patterson-UTI Energy currently has a consensus price target of $11.80, suggesting a potential downside of 4.14%. NOV has a consensus price target of $19.36, suggesting a potential downside of 6.98%. Given Patterson-UTI Energy's stronger consensus rating and higher possible upside, research analysts clearly believe Patterson-UTI Energy is more favorable than NOV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Patterson-UTI Energy	2 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.50
NOV	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.12

Patterson-UTI Energy has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, NOV has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

NOV has a net margin of 1.05% compared to Patterson-UTI Energy's net margin of -2.56%. NOV's return on equity of 3.34% beat Patterson-UTI Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Patterson-UTI Energy	-2.56%	-2.32%	-1.37%
NOV	1.05%	3.34%	1.90%

97.9% of Patterson-UTI Energy shares are held by institutional investors. Comparatively, 93.3% of NOV shares are held by institutional investors. 2.2% of Patterson-UTI Energy shares are held by company insiders. Comparatively, 1.2% of NOV shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Patterson-UTI Energy pays an annual dividend of $0.40 per share and has a dividend yield of 3.2%. NOV pays an annual dividend of $0.36 per share and has a dividend yield of 1.7%. Patterson-UTI Energy pays out -129.0% of its earnings in the form of a dividend. NOV pays out 150.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NOV has raised its dividend for 1 consecutive years. Patterson-UTI Energy is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

NOV beats Patterson-UTI Energy on 10 of the 19 factors compared between the two stocks.

How does NOV compare to TechnipFMC?

NOV (NYSE:NOV) and TechnipFMC (NYSE:FTI) are both energy companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

TechnipFMC has higher revenue and earnings than NOV. TechnipFMC is trading at a lower price-to-earnings ratio than NOV, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NOV	$8.74B	0.85	$145M	$0.24	86.71
TechnipFMC	$9.93B	2.85	$963.90M	$2.62	27.14

NOV presently has a consensus target price of $19.36, indicating a potential downside of 6.98%. TechnipFMC has a consensus target price of $69.00, indicating a potential downside of 2.95%. Given TechnipFMC's stronger consensus rating and higher possible upside, analysts plainly believe TechnipFMC is more favorable than NOV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NOV	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.12
TechnipFMC	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.82

NOV pays an annual dividend of $0.36 per share and has a dividend yield of 1.7%. TechnipFMC pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. NOV pays out 150.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. TechnipFMC pays out 7.6% of its earnings in the form of a dividend. NOV has increased its dividend for 1 consecutive years and TechnipFMC has increased its dividend for 1 consecutive years.

TechnipFMC has a net margin of 10.62% compared to NOV's net margin of 1.05%. TechnipFMC's return on equity of 34.06% beat NOV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NOV	1.05%	3.34%	1.90%
TechnipFMC	10.62%	34.06%	11.30%

In the previous week, NOV had 6 more articles in the media than TechnipFMC. MarketBeat recorded 14 mentions for NOV and 8 mentions for TechnipFMC. TechnipFMC's average media sentiment score of 1.33 beat NOV's score of 1.03 indicating that TechnipFMC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NOV	8 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TechnipFMC	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NOV has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, TechnipFMC has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

93.3% of NOV shares are held by institutional investors. Comparatively, 96.6% of TechnipFMC shares are held by institutional investors. 1.2% of NOV shares are held by insiders. Comparatively, 1.4% of TechnipFMC shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

TechnipFMC beats NOV on 14 of the 18 factors compared between the two stocks.

How does NOV compare to Halliburton?

Halliburton (NYSE:HAL) and NOV (NYSE:NOV) are both energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

In the previous week, Halliburton had 8 more articles in the media than NOV. MarketBeat recorded 22 mentions for Halliburton and 14 mentions for NOV. NOV's average media sentiment score of 1.03 beat Halliburton's score of 0.74 indicating that NOV is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Halliburton	9 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
NOV	8 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Halliburton pays an annual dividend of $0.68 per share and has a dividend yield of 1.6%. NOV pays an annual dividend of $0.36 per share and has a dividend yield of 1.7%. Halliburton pays out 37.4% of its earnings in the form of a dividend. NOV pays out 150.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Halliburton has raised its dividend for 4 consecutive years and NOV has raised its dividend for 1 consecutive years.

Halliburton has a net margin of 6.95% compared to NOV's net margin of 1.05%. Halliburton's return on equity of 19.04% beat NOV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Halliburton	6.95%	19.04%	7.96%
NOV	1.05%	3.34%	1.90%

Halliburton currently has a consensus target price of $42.86, suggesting a potential upside of 3.28%. NOV has a consensus target price of $19.36, suggesting a potential downside of 6.98%. Given Halliburton's stronger consensus rating and higher probable upside, analysts plainly believe Halliburton is more favorable than NOV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Halliburton	1 Sell rating(s)	5 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.71
NOV	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.12

85.2% of Halliburton shares are owned by institutional investors. Comparatively, 93.3% of NOV shares are owned by institutional investors. 0.6% of Halliburton shares are owned by insiders. Comparatively, 1.2% of NOV shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Halliburton has higher revenue and earnings than NOV. Halliburton is trading at a lower price-to-earnings ratio than NOV, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Halliburton	$22.18B	1.56	$1.28B	$1.82	22.80
NOV	$8.74B	0.85	$145M	$0.24	86.71

Halliburton has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, NOV has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

Summary

Halliburton beats NOV on 13 of the 20 factors compared between the two stocks.

How does NOV compare to Helmerich & Payne?

NOV (NYSE:NOV) and Helmerich & Payne (NYSE:HP) are both mid-cap energy companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

In the previous week, NOV had 2 more articles in the media than Helmerich & Payne. MarketBeat recorded 14 mentions for NOV and 12 mentions for Helmerich & Payne. NOV's average media sentiment score of 1.03 beat Helmerich & Payne's score of 0.55 indicating that NOV is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NOV	8 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Helmerich & Payne	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NOV has higher revenue and earnings than Helmerich & Payne. Helmerich & Payne is trading at a lower price-to-earnings ratio than NOV, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NOV	$8.74B	0.85	$145M	$0.24	86.71
Helmerich & Payne	$4.00B	1.00	-$163.70M	-$3.79	N/A

NOV has a net margin of 1.05% compared to Helmerich & Payne's net margin of -9.38%. NOV's return on equity of 3.34% beat Helmerich & Payne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NOV	1.05%	3.34%	1.90%
Helmerich & Payne	-9.38%	-1.16%	-0.48%

93.3% of NOV shares are held by institutional investors. Comparatively, 96.1% of Helmerich & Payne shares are held by institutional investors. 1.2% of NOV shares are held by company insiders. Comparatively, 4.4% of Helmerich & Payne shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

NOV pays an annual dividend of $0.36 per share and has a dividend yield of 1.7%. Helmerich & Payne pays an annual dividend of $1.00 per share and has a dividend yield of 2.5%. NOV pays out 150.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Helmerich & Payne pays out -26.4% of its earnings in the form of a dividend. NOV has raised its dividend for 1 consecutive years. Helmerich & Payne is clearly the better dividend stock, given its higher yield and lower payout ratio.

NOV has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Helmerich & Payne has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

NOV currently has a consensus target price of $19.36, suggesting a potential downside of 6.98%. Helmerich & Payne has a consensus target price of $39.70, suggesting a potential downside of 0.44%. Given Helmerich & Payne's stronger consensus rating and higher probable upside, analysts clearly believe Helmerich & Payne is more favorable than NOV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NOV	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.12
Helmerich & Payne	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

NOV beats Helmerich & Payne on 12 of the 20 factors compared between the two stocks.

Get NOV News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NOV vs. The Competition

Export

Metric	NOV	OIL FLD MCH&EQP Industry	Energy Sector	NYSE Exchange
Market Cap	$7.47B	$1.63B	$10.57B	$23.18B
Dividend Yield	1.73%	3.56%	10.23%	4.10%
P/E Ratio	86.71	60.95	21.11	30.65
Price / Sales	0.85	1.74	1,003.92	14.66
Price / Cash	11.57	9.80	38.74	25.12
Price / Book	1.19	2.66	4.66	4.74
Net Income	$145M	$36.97M	$4.24B	$1.07B
7 Day Performance	-1.73%	-1.90%	-0.26%	1.45%
1 Month Performance	1.61%	-2.21%	2.28%	1.58%
1 Year Performance	71.35%	66.05%	54.41%	28.44%

NOV Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NOV NOV	2.4052 of 5 stars	$20.81 flat	$19.36 -7.0%	+71.3%	$7.47B	$8.74B	86.71	31,605	Positive News Dividend Announcement
BKR Baker Hughes	4.5604 of 5 stars	$66.21 +3.3%	$69.18 +4.5%	+79.8%	$63.61B	$27.73B	21.15	56,000	Positive News
PTEN Patterson-UTI Energy	2.7977 of 5 stars	$12.85 +3.5%	$11.80 -8.2%	+115.2%	$4.71B	$4.83B	N/A	7,900	Positive News
FTI TechnipFMC	4.419 of 5 stars	$73.55 +3.2%	$66.53 -9.5%	+139.6%	$28.42B	$9.93B	28.07	25,407	Positive News
HAL Halliburton	3.9769 of 5 stars	$42.76 +2.4%	$42.45 -0.7%	+108.4%	$34.89B	$22.18B	23.49	46,000	Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NOV) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NOV (NOV) Competitors